Correction

The article “Fever in a traveler returning from Ethiopia” by Ken Koon Wong, MD (Cleve Clin J Med 2020; 87(1):31–42, doi:10.3949/ccjm.87a.19017) contained an error. In Table 7, “Chemoprophylaxis for malaria” on page 40, the entry for doxycycline incorrectly carried a footnote that states this drug can be used in pregnancy. This footnote has been removed. According to the US Food and Drug Administration, “While there are no controlled studies of doxycycline use in pregnant women to show safety, an expert review of published data on experiences with doxycycline use during pregnancy by TERIS—the Teratogen Information System—concluded that therapeutic doses during pregnancy are unlikely to pose a substantial teratogenic risk (quantity and quality of data = limited to fair), but the data are insufficient to state that there is no risk” (https://www.fda.gov/drugs/bioterrorism-and-drug-preparedness/doxycycline-use-pregnant-and-lactating-women).